Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 417-421

  Randall, Leslie M ^a   Monk, Bradley J ^a   Moon, James ^b   Parker, Ricardo ^c   Al Ghazi, Muthana ^a   Wilczynski, Sharon ^d   Fruehauf, John P ^a   Markman, Maurie ^e   Burger, Robert A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Oncotech Inc   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

Cervical cancer; Chemoradiation; In vitro assay; Radiation resistance

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENOPATHY; ONCOLOGY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIOSENSITIVITY; TREATMENT RESPONSE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

BIOPSY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIATION TOLERANCE; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 78149360050     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.010     Document Type: Article

References (26)

1. American Cancer Society Cancer Facts & Figures 2009 2009 American Cancer Society Atlanta
2. L.A.G. Ries, D. Melbert, M. Krapcho, D.G. Stinchcomb, N. Howlader, and M.J. Horner SEER Cancer Statistics Review, 1975-2005 2008 National Cancer Institute Bethesda, MD http://www.seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site
3. R.M. Lanciano, M. Won, L.R. Coia, and G.E. Hanks Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies Int J Radiat Oncol Biol Phys 20 1991 667 676
4. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma NEJM 340 1999 1154
5. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer NEJM 340 1999 1137
6. P.G. Rose, S. Ali, E. Watkins, J.T. Thigpen, G. Deppe, and D.L. Clarke-Pearson Gynecologic Oncology Group. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 19 Jul 1 2007 2804 2810
7. P.J. Eifel, K. Winter, M. Morris, C. Levenback, P.W. Grigsby, and J. Cooper Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 5 Mar 1 2004 872 880
8. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 5 May 1999 1339 1348
9. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 Apr 15 1999 1144 1153 Erratum in:
10. N Engl J Med 341 9 Aug 26 1999 708
11. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 15 Apr 15 1999 1137 1143
12. J. Nilsson, B.K. Lind, and A. Brahme Radiation response of hypoxic and generally heterogeneous tissues Int J Radiat Biol 78 5 May 2002 389 405
13. A. Daşu, and J. Denekamp Superfractionation as a potential hypoxic cell radiosensitizer: prediction of an optimum dose per fraction Int J Radiat Oncol Biol Phys 43 5 Mar 15 1999 1083 1094
14. J. Denekamp, A. Daşu, A. Waites, and B. Littbrand Hyperfractionation as an effective way of overcoming radioresistance Int J Radiat Oncol Biol Phys 42 4 Nov 1 1998 705 709
15. H. Zheng, and P.L. Olive Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice Int J Radiat Biol 71 3 Mar 1997 275 282
16. M.S. O'Reilly Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer Int J Radiat Oncol Biol Phys 69 2 Suppl 2007 S64 S66 [Review]
17. J. Brieger, P. Schroeder, J. Gosepath, and W.J. Mann VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death Int J Mol Med 15 1 Jan 2005 145 151
18. L. Geng, E. Donnelly, G. McMahon, P.C. Lin, E. Sierra-Rivera, and H. Oshinka Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 6 Mar 15 2001 2413 2419
19. C.G. Lee, M. Heijn, E. di Tomaso, G. Griffon-Etienne, M. Ancukiewicz, and C. Koike Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 19 Oct 1 2000 5565 5570
20. M.I. Koukourakis, A. Giatromanolaki, G. Fountzilas, E. Sivridis, K.C. Gatter, and A.L. Harris Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy Clin Cancer Res 6 2 Feb 2000 381 389
21. Z. Fuks, R.S. Persaud, A. Alfieri, M. McLoughlin, D. Ehleiter, and J.L. Schwartz Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo Cancer Res 54 10 May 15 1994 2582 2590
22. C.M. West, S.E. Davidson, S.A. Roberts, and R.D. Hunter Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix Br J Cancer 68 1993 819 823
23. J.P. Fruehauf, and A.G. Bosanquet In vitro determination of drug response: A discussion of clinical applications Princ Pract Oncol Updat 7 1993 1 17
24. B.J. Monk, R.A. Burger, R. Parker, E.H. Radany, L. Redpath, and J.P. Fruehauf Development of an in vitro chemo-radiation response assay for cervical carcinoma Gynecol Oncol 87 2 Nov 2002 193 199
25. D. Tewari, B.J. Monk, M.S. Al-Ghazi, R. Parker, J.D. Heck, and R.A. Burger Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study Gynecol Oncol 99 1 Oct 2005 84 91
26. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines) J Natl Cancer Inst 92 2000 205 216